SUDHIR NAGARAJA: Open Payments
NPI 1306054325 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 19 payments from 5 companies in 2025. Trend: 2023 $68 · 2024 $31 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 6 | $149 |
| ABBVIE INC. | 8 | $135 |
| Lundbeck LLC | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: VRAYLAR, HETLIOZ, REXULTI, FANAPT, CAPLYTA.
Industry payments across VA — which companies pay providers there.
